{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:59:31Z","timestamp":1790513971834,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Solange Gauthier Karsh Endowment Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13395-019-0201-6","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T09:04:11Z","timestamp":1558688651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy"],"prefix":"10.1186","volume":"9","author":[{"given":"Neena","family":"Lala-Tabbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Lejmi-Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Timusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Fukano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"St-Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"LaCasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-646X","authenticated-orcid":false,"given":"Robert G.","family":"Korneluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14:58\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"201_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2004.12.007","volume":"119","author":"IW Mckinnell","year":"2004","unstructured":"Mckinnell IW, Rudnicki MA. Molecular mechanisms of muscle atrophy. Cell. 2004;119:907\u201310.","journal-title":"Cell."},{"issue":"2001","key":"201_CR3","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"1704","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Lai VK, Nunez L, Clarke BA. Skeletal muscle atrophy identification of ubiquitin ligases required for skeletal muscle atrophy. Science (80- ). 2001;1704(2001):1704\u20138.","journal-title":"Science (80- )."},{"issue":"25","key":"201_CR4","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001;98(25):14440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"201_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai D, Frantz JD, Tawa NE, Melendez PA, Oh BC, Lidov HGW, et al. IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice. Cell. 2004;119(2):285\u201398.","journal-title":"Cell."},{"issue":"11","key":"201_CR6","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1172\/JCI28721","volume":"116","author":"F Mourkioti","year":"2006","unstructured":"Mourkioti F, Kratsios P, Luedde T, Song Y, Delafontaine P, Adami R, et al. Targeted ablation of IKK2 improves skeletal muscle strength , maintains mass , and promotes regeneration. J Clin Invest. 2006;116(11):2945\u201354.","journal-title":"J Clin Invest"},{"issue":"7","key":"201_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00109-008-0308-4","volume":"86","author":"F Mourkioti","year":"2008","unstructured":"Mourkioti F, Rosenthal N. NF-\u03baB signaling in skeletal muscle: prospects for intervention in muscle diseases. J Mol Med. 2008;86(7):747\u201359.","journal-title":"J Mol Med"},{"key":"201_CR8","first-page":"R1165","volume":"279","author":"Y Li","year":"2000","unstructured":"Li Y, Reid MB. NF-\u03baB mediates the protein loss induced by TNF-\u03b1 in differentiated skeletal muscle myotubes. Am J Phys. 2000;279:R1165\u201370.","journal-title":"Am J Phys"},{"issue":"6","key":"201_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1083\/jcb.200909117","volume":"188","author":"A Mittal","year":"2010","unstructured":"Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, Li H, et al. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol. 2010;188(6):833\u201349.","journal-title":"J Cell Biol"},{"key":"201_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1096\/fj.08-114249","volume":"23","author":"GD Van","year":"2009","unstructured":"Van GD, Damrauer JS, Jackman RW, Kandarian SC. The IkB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy. FASEB J. 2009;23:362\u201370.","journal-title":"FASEB J"},{"key":"201_CR11","first-page":"86","volume":"99","author":"V Dutt","year":"2015","unstructured":"Dutt V, Gupta S, Dabur R, Injeti E, Mittal A. Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action. Pharmacol Res Elsevier Ltd. 2015;99:86\u2013100.","journal-title":"Pharmacol Res Elsevier Ltd"},{"issue":"5","key":"201_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jcph.842","volume":"57","author":"JM Donovan","year":"2017","unstructured":"Donovan JM, Zimmer M, Offman E, Grant T, Jirousek M. A novel NF-\u03baB inhibitor, edasalonexent (CAT-1004), in development as a disease-modifying treatment for patients with Duchenne muscular dystrophy: phase 1 safety, pharmacokinetics, and pharmacodynamics in adult subjects. J Clin Pharmacol. 2017;57(5):627\u201339.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"201_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","volume":"80","author":"N Roy","year":"1995","unstructured":"Roy N, Mahadevan MS, McLean M, Shutter G, Yaraghi Z, Farahani R, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 1995;80(1):167\u201378.","journal-title":"Cell."},{"key":"201_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/379349a0","volume":"379","author":"P Liston","year":"1996","unstructured":"Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349\u201353.","journal-title":"Nature."},{"issue":"2","key":"201_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1074\/jbc.M509381200","volume":"281","author":"T Samuel","year":"2006","unstructured":"Samuel T, Welsh K, Lober T, Zapata JM, Reed JC. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem. 2006;281(2):1080\u201390.","journal-title":"J Biol Chem"},{"issue":"8","key":"201_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrc2889","volume":"10","author":"Mads Gyrd-Hansen","year":"2010","unstructured":"Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-\u03baB, inflammation and cancer. Nat rev Cancer. Nat Publ Group; 2010;10(8):561\u2013574.","journal-title":"Nature Reviews Cancer"},{"issue":"11","key":"201_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2012.06.004","volume":"33","author":"ST Beug","year":"2012","unstructured":"Beug ST, Cheung HH, LaCasse EC, Korneluk RG. Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol Elsevier Ltd. 2012;33(11):535\u201345.","journal-title":"Trends Immunol Elsevier Ltd"},{"issue":"12","key":"201_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ni.1676","volume":"9","author":"BJ Zarnegar","year":"2008","unstructured":"Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J, et al. Noncanonical NF-\u03baB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol. 2008;9(12):1371\u20138.","journal-title":"Nat Immunol"},{"issue":"5467","key":"201_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1126\/science.288.5467.874","volume":"288","author":"Y Yang","year":"2000","unstructured":"Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science (80- ). 2000;288(5467):874\u20138.","journal-title":"Science (80- )"},{"issue":"33","key":"201_CR20","doi-asserted-by":"publisher","first-page":"11778","DOI":"10.1073\/pnas.0711122105","volume":"105","author":"DJ Mahoney","year":"2008","unstructured":"Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, et al. Both cIAP1 and cIAP2 regulate TNF -mediated NF- B activation. Proc Natl Acad Sci. 2008;105(33):11778\u201383.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"201_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.200801010","volume":"182","author":"JE Vince","year":"2008","unstructured":"Vince JE, Chau D, Callus B, Wong WWL, Hawkins CJ, Schneider P, et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNF\u03b1. J Cell Biol. 2008;182(1):171\u201384.","journal-title":"J Cell Biol"},{"key":"201_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00034","volume":"5","author":"EK Enwere","year":"2014","unstructured":"Enwere EK, LaCasse EC, Adam NJ, Korneluk RG. Role of the TWEAK-Fn14-cIAP1-NF-\u03baB signaling axis in the regulation of myogenesis and muscle homeostasis. Front Immunol. 2014;5:1\u201313.","journal-title":"Front Immunol"},{"issue":"5","key":"201_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/hmg\/dds493","volume":"22","author":"EK Enwere","year":"2013","unstructured":"Enwere EK, Boudreault L, Holbrook J, Timusk K, Earl N, Lacasse E, et al. Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice. Hum Mol Genet. 2013;22(5):867\u201378.","journal-title":"Hum Mol Genet"},{"issue":"246","key":"201_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.2003086","volume":"5","author":"EK Enwere","year":"2012","unstructured":"Enwere EK, Holbrook J, Lejmi-Mrad R, Vineham J, Timusk K, Sivaraj B, et al. TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF- B signaling pathway. Sci Signal. 2012;5(246):1\u201312.","journal-title":"Sci Signal"},{"issue":"8","key":"201_CR25","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1128\/MCB.25.8.3348-3356.2005","volume":"25","author":"DB Conze","year":"2005","unstructured":"Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh W, Mak T, et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol. 2005;25(8):3348\u201356.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"201_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/MCB.26.2.699-708.2006","volume":"26","author":"D Conte","year":"2006","unstructured":"Conte D, Holcik M, Lefebvre CA, Lacasse E, Picketts DJ, Wright KE, et al. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol. 2006;26(2):699\u2013708.","journal-title":"Mol Cell Biol"},{"key":"201_CR27","doi-asserted-by":"crossref","unstructured":"Motohashi N, Asakura Y, Asakura A. Isolation, culture, and transplantation of muscle satellite cells. J Vis Exp. 2014;(86):1\u20137.","DOI":"10.3791\/50846"},{"issue":"19","key":"201_CR28","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.15252\/embj.201592060","volume":"34","author":"KN Heard","year":"2015","unstructured":"Heard KN, Bertrand MJM, Barker PA. cIAP 2 supports viability of mice lacking cIAP1 and XIAP. EMBO J. 2015;34(19):2393\u20135.","journal-title":"EMBO J"},{"issue":"6","key":"201_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJM Bertrand","year":"2008","unstructured":"Bertrand MJM, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008;30(6):689\u2013700.","journal-title":"Mol Cell"},{"issue":"28","key":"201_CR30","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1200\/JCO.2013.52.3993","volume":"32","author":"JR Infante","year":"2014","unstructured":"Infante JR, Dees EC, Olszanski AJ, Dhuria SV, Sen S, Cameron S, et al. Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2014;32(28):3103\u201310.","journal-title":"J Clin Oncol"},{"issue":"3","key":"201_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/MCO.0b013e328360272d","volume":"16","author":"Y Wang","year":"2013","unstructured":"Wang Y, Pessin JE. Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care. 2013;16(3):243\u201350.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx \/ atrogin-1. Am J Physiol Endocrinol Metab. 2014;307:E469\u201384.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"201_CR33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1083\/jcb.201006098","volume":"191","author":"PK Paul","year":"2010","unstructured":"Paul PK, Gupta SK, Bhatnagar S, Panguluri SK, Darnay BG, Choi Y, et al. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol. 2010;191(7):1395\u2013411.","journal-title":"J Cell Biol"},{"issue":"3","key":"201_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MCO.0b013e328351c3fc","volume":"15","author":"A Kumar","year":"2012","unstructured":"Kumar A, Bhatnagar S, Paul PK. TWEAK and TRAF6 regulate skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care. 2012;15(3):233\u20139.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"issue":"7","key":"201_CR35","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1128\/MCB.06351-11","volume":"32","author":"PK Paul","year":"2012","unstructured":"Paul PK, Bhatnagar S, Mishra V, Srivastava S, Darnay BG, Choi Y, et al. The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol. 2012;32(7):1248\u201359.","journal-title":"Mol Cell Biol"},{"issue":"13","key":"201_CR36","doi-asserted-by":"publisher","first-page":"9470","DOI":"10.1074\/jbc.M109.071043","volume":"285","author":"AP Mao","year":"2010","unstructured":"Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q, et al. Virus-triggered ubiquitination of TRAF3\/6 by cIAP1\/2 is essential for induction of interferon-\u03b2 (IFN-\u03b2) and cellular antiviral response. J Biol Chem. 2010;285(13):9470\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"201_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2010.09.008","volume":"40","author":"M Hinz","year":"2010","unstructured":"Hinz M, Stilmann M, Arslan S\u00c7, Khanna KK, Dittmar G, Scheidereit C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-\u03baB activation. Mol Cell. 2010;40(1):63\u201374.","journal-title":"Mol Cell"},{"issue":"4","key":"201_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1172\/JCI30556","volume":"117","author":"S Acharyya","year":"2007","unstructured":"Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PML, Carathers M, et al. Interplay of IKK\/NF-\u03baB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest. 2007;117(4):889\u2013901.","journal-title":"J Clin Invest"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-019-0201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13395-019-0201-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-019-0201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T23:20:12Z","timestamp":1590189612000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-019-0201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1186\/s13395-019-0201-6","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments were approved by the University of Ottawa\u2019s Animal Care Committee (protocol CHEO-1695) respecting the standards for ethical use of animals stipulated by the Canadian Council on Animal Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}